**Core Concept:** Myasthenia gravis (MG) is a chronic autoimmune disorder where antibodies target and inhibit the acetylcholine receptors (AChRs) at neuromuscular junction, leading to muscle weakness and fatigue.

**Why the Correct Answer is Right:** The correct answer represents medications or conditions that do NOT worsen or exacerbate the symptoms of myasthenia gravis (MG).

**Why Each Wrong Option is Incorrect:**

A. **Option A:** Anticholinesterase drugs like neostigmine and pyridostigmine are indicated in MG as they increase the acetylcholine (ACh) levels at the neuromuscular junction, thereby improving muscle strength and reducing fatigue.

B. **Option B:** Corticosteroids, like prednisolone, are immunosuppressants used to reduce inflammation and autoimmune responses, which can be beneficial in MG management.

C. **Option C:** Immunosuppressive agents like azathioprine, cyclosporine, and cyclophosphamide are used to suppress the immune system and reduce autoimmune reactions, which can be beneficial in MG management.

D. **Option D:** Immunoglobulins, such as intravenous immunoglobulin (IVIg) and plasma exchange, are used to remove autoantibodies from the blood, thereby improving neuromuscular transmission in MG cases.

**Clinical Pearl:** Myasthenia gravis (MG) management involves a combination of medications like anticholinesterase drugs, corticosteroids, immunosuppressive agents, and immunoglobulins. The correct treatment selection depends on the disease severity, patient's response, and potential side effects.

**Core Concept:**

Myasthenia gravis (MG) is a neuromuscular disorder caused by autoimmunity, leading to impaired neuromuscular transmission. AChE inhibitors, corticosteroids, immunosuppressive agents, and immunoglobulins are medications that can improve neuromuscular transmission in MG patients.

**Why Each Wrong Option is Incorrect:**

A. Anticholinesterase drugs, as mentioned above, are beneficial in MG management.

B. Corticosteroids, such as prednisolone, are immunosuppressants that reduce inflammation and autoimmune reactions, which can be beneficial in MG management.

C. Immunosuppressive agents like azathioprine, cyclosporine, and cyclophosphamide are used to suppress the immune system and remove autoantibodies from the blood, thereby improving neuromuscular transmission in MG patients.

D. Immunoglobulins like intravenous immunoglobulin (IVIg) and plasma exchange can remove autoantibodies from the blood, improve neuromuscular transmission in MG patients.

**Clinical Pearl:**

Myasthenia gravis (MG) management involves a tailored approach based on disease severity, patient response, and potential side effects. Choosing the correct medication and dosing is essential for optimal treatment outcomes.

**Core Concept:**

Myasthenia gravis (MG) is a disorder involving autoimmunity that leads to